Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Wayne

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Blood|October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemiaAlan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
American Journal of Hematology|April 5, 2012
Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challengesNirali N Shah, Ulrike Bacher, Terry Fry, et al.
The Journal of Allergy and Clinical Immunology|December 14, 2011
Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiencyChimene Kesserwan, Robert Sokolic, Edward W Cowen, et al.
Cancers|September 12, 2017
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALLEtai Adam, Hye Na Kim, Eun Ji Gang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignanciesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.
Blood|July 5, 2011
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiencyRobert Sokolic, Irina Maric, Chimene Kesserwan, et al.
Blood|January 18, 2018
A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortiumWeili Sun, Timothy Triche, Jemily Malvar, et al.
Blood|December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemiaWaleed Haso, Daniel W Lee, Nirali N Shah, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Blood|October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemiaAlan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
American Journal of Hematology|April 5, 2012
Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challengesNirali N Shah, Ulrike Bacher, Terry Fry, et al.
The Journal of Allergy and Clinical Immunology|December 14, 2011
Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiencyChimene Kesserwan, Robert Sokolic, Edward W Cowen, et al.
Cancers|September 12, 2017
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALLEtai Adam, Hye Na Kim, Eun Ji Gang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignanciesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.
Blood|July 5, 2011
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiencyRobert Sokolic, Irina Maric, Chimene Kesserwan, et al.
Blood|January 18, 2018
A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortiumWeili Sun, Timothy Triche, Jemily Malvar, et al.
Blood|December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemiaWaleed Haso, Daniel W Lee, Nirali N Shah, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Pageof 11